Novartis continues to ‘reimagine’ itself, as Alcon spin-off completed by Anna Smith | Apr 10, 2019 | News | 0 The new standalone company is worth up to 28 billion Swiss francs. Read More
Novartis to spin off eye unit Alcon by Selina McKee | Jun 29, 2018 | News | 0 Novartis has announced plans to spin off its eye-care unit Alcon into a standalone entity. Read More